eXoZymes Statistics
Total Valuation
eXoZymes has a market cap or net worth of $133.11 million. The enterprise value is $129.33 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
eXoZymes has 8.39 million shares outstanding. The number of shares has increased by 30.51% in one year.
| Current Share Class | 8.39M |
| Shares Outstanding | 8.39M |
| Shares Change (YoY) | +30.51% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 25.58% |
| Owned by Institutions (%) | 47.59% |
| Float | 6.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 24.71 |
| P/TBV Ratio | 24.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.53, with a Debt / Equity ratio of 0.25.
| Current Ratio | 4.53 |
| Quick Ratio | 4.36 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -940.69% and return on invested capital (ROIC) is -125.71%.
| Return on Equity (ROE) | -940.69% |
| Return on Assets (ROA) | -99.79% |
| Return on Invested Capital (ROIC) | -125.71% |
| Return on Capital Employed (ROCE) | -138.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$269,022 |
| Employee Count | 31 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2,143 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.07% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +15.07% |
| 50-Day Moving Average | 13.96 |
| 200-Day Moving Average | 12.94 |
| Relative Strength Index (RSI) | 57.64 |
| Average Volume (20 Days) | 2,688 |
Short Selling Information
The latest short interest is 13,458, so 0.16% of the outstanding shares have been sold short.
| Short Interest | 13,458 |
| Short Previous Month | 14,548 |
| Short % of Shares Out | 0.16% |
| Short % of Float | 0.22% |
| Short Ratio (days to cover) | 0.60 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.00M |
| Pretax Income | -8.34M |
| Net Income | -8.34M |
| EBITDA | -8.72M |
| EBIT | -9.00M |
| Earnings Per Share (EPS) | -$1.02 |
Full Income Statement Balance Sheet
The company has $5.10 million in cash and $1.32 million in debt, giving a net cash position of $3.78 million or $0.45 per share.
| Cash & Cash Equivalents | 5.10M |
| Total Debt | 1.32M |
| Net Cash | 3.78M |
| Net Cash Per Share | $0.45 |
| Equity (Book Value) | 5.37M |
| Book Value Per Share | 0.64 |
| Working Capital | 4.37M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$10.24 million and capital expenditures -$305,335, giving a free cash flow of -$10.54 million.
| Operating Cash Flow | -10.24M |
| Capital Expenditures | -305,335 |
| Free Cash Flow | -10.54M |
| FCF Per Share | -$1.26 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |